We are live on ! Find out more
DG

David Greenspan Slate Path Capital

AUM $7.22B
1-Year Est. Return 110.75%
 

David Greenspan is the founder of Slate Path Capital, a long/short equity firm with roots in the Tiger Management network. The firm conducts fundamental research across sectors with an emphasis on differentiated views rather than index hugging. Greenspan’s filings attract attention among investors who follow Tiger Cub-style managers.

This Fund
S&P 500
This Quarter Est. Return
+26.61%
1 Year Est. Return
+110.75%
3 Year Est. Return
+393.62%
5 Year Est. Return
+449.87%
10 Year Est. Return
+5,767.79%
AUM
$1.86B
AUM Growth
+$346M
Cap. Flow
+$9.81M
Cap. Flow %
0.53%
Top 10 Hldgs %
81.62%
Holding
33
New
4
Increased
6
Reduced
3
Closed
6

Sector Composition

Rank Sector Weight
1 Communication Services 39.37%
2 Materials 28.71%
3 Healthcare 20.5%
4 Industrials 7.2%
5 Energy 3.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ENDP
26
DELISTED
Endo International plc
ENDP
$1.64M 0.09%
+350,000
New +$1.56M
X
27
DELISTED
US Steel
X
$456K 0.02%
40,000
CYCN icon
28
Cyclerion Therapeutics
CYCN
$18.2M
-44,000
Closed -$10.7M
GE icon
29
GE Aerospace
GE
$361B
-2,076,589
Closed -$92.5M
PDD icon
30
Pinduoduo
PDD
$126B
-65,000
Closed -$2.09M
QQQ icon
31
CALL
Invesco QQQ Trust
QQQ
$486B
-21,000
Closed -$3.96M
SDRL
32
DELISTED
Seadrill Limited Common Stock
SDRL
-390,000
Closed -$819K
MDR
33
DELISTED
McDermott International
MDR
-290,000
Closed -$586K

Similar funds

David Greenspan's Q4 2019 Portfolio in Review

As of Q4 2019, David Greenspan held 33 positions worth $1.86B, up 23% from $1.51B the previous quarter. Its ten largest holdings account for 82% of the portfolio.

David Greenspan's Q4 2019 filing shows 4 new, 6 increased, 3 reduced and 6 closed positions. Its largest new stake was Bausch Health: 5,579,948 shares worth $167M. The largest sale was Medicines Co, an estimated $192M.

By sector, the portfolio is most concentrated in Communication Services at 39% of assets, down from 45% a quarter earlier, followed by Materials and Healthcare.

  • David Greenspan's largest Q4 2019 buy was Bausch Health: 5,579,948 shares worth $167M.
  • David Greenspan added most to Freeport-McMoran in Q4 2019, an estimated $74.6M increase.
  • David Greenspan's biggest Q4 2019 reduction was Medicines Co, cutting an estimated $192M.
  • David Greenspan fully exited GE Aerospace in Q4 2019, selling an estimated $92.5M.
  • David Greenspan's ten largest holdings make up 82% of its $1.86B portfolio in Q4 2019.
  • David Greenspan opened 4 new positions and closed 6 in Q4 2019.
  • David Greenspan's portfolio value rose 23% quarter-over-quarter to $1.86B.

Based on Slate Path Capital's 13F filing for Q4 2019, filed 14 Feb 2020.